Joel Iff

Company: Sarepta Therapeutics

Job title: Executive Director, Global Access, Value & Evidence

Seminars:

Robust Evidence Generation & Value Demonstration Activities to Support Commercialization 2:00 pm

Boosting the value proposition of commercial therapies through real-world evidence (RWE) and publications Navigating guidance on incorporating RWE into regulatory and HTA submissions Key considerations when working on commercial programmes with payer uncertainty over durability and therapeutic benefitRead more

day: Conference Day Two